Facebook Twitter YouTube LinkedIn Reddit

Zentek Ltd.

Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.

InvestorIntel Features on Zentek Ltd.

Zentek is well positioned to commercialize several revolutionary nanotech graphene health products in 2022

Zentek Ltd. (TSXV: ZEN) (formerly ZEN Graphene Solutions Ltd.) is a trail blazing company in the world of  nanotechnology and […]

Greg Fenton on the significant medical market interest in Zentek’s ZENGuard™ nanotech coatings, plus its new carbon-based icephobic coating

In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about Zentek’s new icephobic […]

ZEN Graphene’s Greg Fenton discusses Health Canada’s approval of the ‘gold standard’ for face masks

In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: […]

Company Overview

Website

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is commercializing ZENGuard™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global exclusive commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

News Releases

View All News

Facebook Twitter YouTube LinkedIn Reddit